PD-L1 Expression and Tumour Microenvironment Patterns in Resected Non-Small-Cell Lung Cancer

Background and Objectives: Although perioperative immunotherapy is implemented as a standard of care for resected non-small cell lung cancer (NSCLC), there is unmet need for predictive biomarkers as programmed death-ligand 1 (PD-L1) is not the perfect one. The functionality of tumour-infiltrating im...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Medicina (Kaunas, Lithuania) Ročník 60; číslo 3; s. 482
Hlavní autoři:	Gurevičienė, Giedrė, Matulionė, Jurgita, Poškienė, Lina, Miliauskas, Skaidrius, Žemaitis, Marius
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Switzerland MDPI AG 01.03.2024 MDPI
Témata:	B7-H1 Antigen - metabolism Biomarkers, Tumor - metabolism Cancer Cancer therapies Carcinoma, Non-Small-Cell Lung - metabolism Carcinoma, Non-Small-Cell Lung - surgery CD8-Positive T-Lymphocytes - metabolism Chemotherapy Chronic obstructive pulmonary disease FDA approval Health aspects Humans Immunotherapy Lung cancer Lung cancer, Non-small cell Lung diseases Lung Neoplasms - pathology Lymphocytes Lymphocytes, Tumor-Infiltrating - metabolism Medical equipment and supplies industry Medical prognosis Medical test kit industry Metastasis non-small cell lung cancer Prognosis programmed death-ligand 1 Radiation therapy Squamous cell carcinoma Statistical analysis T cells Tumor Microenvironment Tumors tumour microenvironment Lithuania United States United States > US non-small cell lung cancer programmed death-ligand 1 tumour microenvironment
ISSN:	1648-9144, 1010-660X, 1648-9144
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!